Stanislav Glezer - May 1, 2024 Form 4 Insider Report for Inogen Inc (INGN)

Role
EVP, R&D & Chief Med. Officer
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
May 1, 2024
Transactions value $
-$117,700
Form type
4
Date filed
5/3/2024, 06:14 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Options Exercise $0 +32.6K +202.64% $0.00 48.7K May 1, 2024 Direct
transaction INGN Common Stock Tax liability -$118K -16.7K -34.25% $7.05 32K May 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Options Exercise $0 -32.6K -100% $0.00* 0 May 1, 2024 Common Stock 32.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.
F2 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3 Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024